
Apollomics Inc.
Nasdaq · Pharmaceutical Preparations
Company Overview
A concise company profile alongside the latest public filing activity.
Apollomics Inc. is a clinical-stage biopharmaceutical company developing cancer therapies, including small-molecule and antibody-based drug candidates targeting angiogenesis, immuno-oncology, and precision medicine pathways. The company is headquartered in Foster City, California, and conducts clinical trials in the United States and China.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Chen Yi-KueiChief Operating Officer | Buy | $300K | 20,000at $15.00 | Aug 14, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable APLM activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.